CIMERLI (ranibizumab-eqrn)

**Product type:** Human Prescription Drug

**Active ingredient:** RANIBIZUMAB

**Strength:** .3 mg/.05mL

**Dosage form:** Injection, Solution

**Route:** Intravitreal

**Labeler:** Coherus BioSciences Inc

**Marketing category:** BLA (BLA761165)

**Pharmacologic class:** Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]